Klucis E, Crane D I, Hughes J L, Poulos A, Masters C J
Division of Science and Technology, Griffith University, Brisbane, Australia.
Biochim Biophys Acta. 1991 Jul 8;1074(2):294-301. doi: 10.1016/0304-4165(91)90167-f.
The peroxisomal compartment in mouse liver was investigated using rate sedimentation of liver subfractions on sucrose density gradients. Treatment of mice with clofibrate, a hypolipidemic agent and peroxisome proliferator, resulted in the formation of small particles which were devoid of catalase and urate oxidase, but which were identified as peroxisomal on the basis of content of the clofibrate-induced peroxisomal beta-oxidation enzymes (fatty acyl-CoA oxidase, hydratase/dehydrogenase bifunctional protein, and thiolase) and the 68 kDa peroxisomal integral membrane protein. Immunoelectron microscopy confirmed the membrane-bound organellar nature and enzyme composition of these particles. These particles were absent in normal mice, and were increased to a maximal level within 2 days of clofibrate treatment. These data have been taken as indicative of a role of these particles in the mechanism of drug-induced peroxisome proliferation.
利用肝亚组分在蔗糖密度梯度上的速率沉降法对小鼠肝脏中的过氧化物酶体区室进行了研究。用降血脂药物和过氧化物酶体增殖剂氯贝丁酯处理小鼠,导致形成了不含过氧化氢酶和尿酸氧化酶的小颗粒,但根据氯贝丁酯诱导的过氧化物酶体β氧化酶(脂肪酰辅酶A氧化酶、水合酶/脱氢酶双功能蛋白和硫解酶)以及68 kDa过氧化物酶体整合膜蛋白的含量,这些小颗粒被鉴定为过氧化物酶体。免疫电子显微镜证实了这些颗粒的膜结合细胞器性质和酶组成。正常小鼠中不存在这些颗粒,在氯贝丁酯处理2天内其数量增加到最大水平。这些数据被认为表明了这些颗粒在药物诱导的过氧化物酶体增殖机制中的作用。